Scalebridge Capital

About The Fund

Scalebridge Capital is an investment fund that acts as a scaling partner for inspiring future builders. They back exceptional founders who are reshaping the future of various industries such as BioTech, IoT & Wearables, AI & Big Data, HealthTech & Fitness, Analytics, Medical Devices & Hospital Services, Robotics, Healthcare & Wellness, Nanotechnology, and Consumer sectors with a special focus on women-led enterprises. Scalebridge Capital primarily invests in Seed and Series A stages, with an investment sweet spot of $700,000, a minimum investment threshold of $200,000, and an upper limit of $2,000,000. Their specialty lies in early-stage ventures, helping them scale by offering hands-on support throughout their scaling journey, which is not limited to capital. They emphasize a prepared-mind, thesis-driven approach and consider themselves a 'first check' investor who values the founder's vision and strives to provide end-to-end operational, commercial, and fundraising support. Geographically, Scalebridge Capital predominantly operates across Europe and exhibits domain expertise in each of their investment areas, combined with global partnerships and ecosystem connectivity which bolsters their portfolio companies’ growth. In addition to venture capital investments, they also provide services in buy-side and sell-side M&A, capital raising, exit planning, strategic partnerships, and cross-border transactions. Scalebridge Capital participates in co-investments and supports underrepresented founders beyond capital investments. They claim success in advising companies such as Eppione, The Charlesworth Group, and the prosperity company in various capacities including strategic sales and funding rounds.